Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A

Lingjiao Meng1,2, Sheng Chang1, Yang Sang3

  • 1Tumor Research Institute, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050017, People's Republic of China.

Abstract

Insights

Circular RNA CCDC85A (circCCDC85A) acts as a tumor suppressor in breast cancer by sponging miR-550a-5p. This interaction restores MOB1A expression, inhibiting cancer progression and proliferation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in disease, including cancer, often by regulating microRNAs (miRNAs).
  • Aberrant circRNA expression is implicated in various pathologies, necessitating investigation into specific circRNAs like circCCDC85A in cancer development.

Purpose of the Study:

  • To investigate the role of circCCDC85A as a potential molecular sponge for miR-550a-5p.
  • To determine the impact of circCCDC85A on breast cancer progression, proliferation, migration, and invasion.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and fluorescence in situ hybridization (FISH) for circCCDC85A expression analysis.
  • Cell proliferation, migration, and invasion assays (CCK-8, colony formation, wound healing, Transwell) to assess functional effects.
  • Luciferase reporter assays, RNA-binding protein immunoprecipitation (RIP), and Western blot to elucidate molecular interactions and mechanisms.

Main Results:

  • circCCDC85A expression was significantly lower in breast cancer tissues compared to normal tissues.
  • Overexpression of circCCDC85A suppressed breast cancer cell proliferation, migration, and invasion, while knockdown enhanced these properties.
  • circCCDC85A functioned as a molecular sponge for miR-550a-5p, leading to increased expression of MOB1A, a target of miR-550a-5p.

Conclusions:

  • circCCDC85A acts as a tumor suppressor in breast cancer by sponging miR-550a-5p.
  • This sponging activity enhances MOB1A expression, thereby inhibiting breast cancer progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K